We provide you with 20 years of free, institutional-grade data for RYTM stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of RYTM. Explore the full financial landscape of RYTM stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$10,770,727
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Shulman Joseph | Sale | -16,781 | $105.3 | $1,767,006 | 2025-09-04 |
| Shulman Joseph | Derivatives Exercise | 16,781 | 2025-09-04 | ||
| Shulman Joseph | Sale | -4,188 | $100.07 | $419,091 | 2025-08-25 |
| Shulman Joseph | Derivatives Exercise | 4,188 | 2025-08-25 | ||
| German Christopher Paul | Sale | -1,500 | $95 | $142,500 | 2025-08-14 |
| German Christopher Paul | Derivatives Exercise | 1,500 | 2025-08-14 | ||
| Smith Hunter C | Sale | -28,088 | $96.33 | $2,705,779 | 2025-08-14 |
| Smith Hunter C | Derivatives Exercise | 28,088 | 2025-08-14 | ||
| Shulman Joseph | Sale | -3,984 | $90.08 | $358,891 | 2025-08-13 |
| Shulman Joseph | Derivatives Exercise | 3,984 | 2025-08-13 | ||
| Cramer Pamela J. | Sale | -1,520 | $85.93 | $130,614 | 2025-07-29 |
| Cramer Pamela J. | Derivatives Exercise | 3,125 | 2025-07-29 | ||
| Shulman Joseph | Sale | -7,969 | $75.56 | $602,177 | 2025-07-11 |
| Shulman Joseph | Derivatives Exercise | 7,969 | 2025-07-11 | ||
| Smith Hunter C | Sale | -42,120 | $75.38 | $3,175,183 | 2025-07-11 |
| Smith Hunter C | Derivatives Exercise | 42,120 | 2025-07-11 | ||
| German Christopher Paul | Sale | -3,817 | $76.75 | $292,955 | 2025-07-11 |
| German Christopher Paul | Derivatives Exercise | 2,850 | 2025-07-11 | ||
| Cramer Pamela J. | Sale | -15,572 | $75.55 | $1,176,533 | 2025-07-11 |
| Cramer Pamela J. | Derivatives Exercise | 15,572 | 2025-07-11 | ||
| Smith Hunter C | Derivatives Exercise | 6,986 | 2025-07-08 | ||
| Garfield Alastair | Sale | -1,319 | $64.81 | $85,484 | 2025-07-03 |
| Garfield Alastair | Derivatives Exercise | 4,445 | 2025-07-03 | ||
| MCGIRR DAVID W J | Derivatives Exercise | 4,000 | 2025-06-23 | ||
| TETRAULT LYNN A. | Derivatives Exercise | 4,000 | 2025-06-23 | ||
| Arbuckle Stuart A | Derivatives Exercise | 4,000 | 2025-06-23 | ||
| GOOD JENNIFER L | Derivatives Exercise | 4,000 | 2025-06-23 | ||
| JEAN CHRISTOPHE | Derivatives Exercise | 4,000 | 2025-06-23 | ||
| Mathers Edward T | Derivatives Exercise | 4,000 | 2025-06-23 | ||
| Bedrosian Camille L | Derivatives Exercise | 4,000 | 2025-06-23 | ||
| German Christopher Paul | Sale | -2,069 | $67.19 | $139,016 | 2025-06-12 |
| German Christopher Paul | Derivatives Exercise | 1,069 | 2025-06-12 | ||
| Cramer Pamela J. | Sale | -7,031 | $68.05 | $478,435 | 2025-06-10 |
| Cramer Pamela J. | Derivatives Exercise | 7,031 | 2025-06-10 | ||
| MCGIRR DAVID W J | Sale | -65,431 | $65.15 | $4,262,594 | 2025-06-05 |
| MCGIRR DAVID W J | Derivatives Exercise | 65,431 | 2025-06-05 | ||
| Meeker David P | Sale | -43,620 | $65.04 | $2,837,180 | 2025-06-05 |
| Meeker David P | Derivatives Exercise | 43,620 | 2025-06-05 | ||
| Smith Hunter C | Sale | -23,400 | $60.93 | $1,425,746 | 2025-06-03 |
| Smith Hunter C | Derivatives Exercise | 23,400 | 2025-06-03 | ||
| Cramer Pamela J. | Sale | -7,031 | $65.09 | $457,663 | 2025-05-01 |
| Cramer Pamela J. | Derivatives Exercise | 7,031 | 2025-05-01 | ||
| Mazabraud Yann | Sale | -6,745 | $65.08 | $438,946 | 2025-05-01 |
| Mazabraud Yann | Derivatives Exercise | 21,780 | 2025-04-16 | ||
| Cramer Pamela J. | Sale | -20,760 | $58.36 | $1,211,475 | 2025-04-10 |
| Cramer Pamela J. | Derivatives Exercise | 20,760 | 2025-04-10 | ||
| Mazabraud Yann | Sale | -17,750 | $60.37 | $1,071,637 | 2025-04-10 |
| German Christopher Paul | Sale | -344 | $54.23 | $18,655 | 2025-03-24 |
| German Christopher Paul | Derivatives Exercise | 1,163 | 2025-03-24 | ||
| Mazabraud Yann | Sale | -75,000 | $50.79 | $3,809,370 | 2025-03-18 |
| Mazabraud Yann | Derivatives Exercise | 75,000 | 2025-03-18 | ||
| Lee Jennifer Kayden | Sale | -2,035 | $57.22 | $116,443 | 2025-02-19 |
| Lee Jennifer Kayden | Derivatives Exercise | 5,500 | 2025-02-19 | ||
| German Christopher Paul | Sale | -635 | $57.22 | $36,335 | 2025-02-19 |
| German Christopher Paul | Derivatives Exercise | 1,807 | 2025-02-19 | ||
| Cramer Pamela J. | Sale | -982 | $57.22 | $56,190 | 2025-02-19 |
| Cramer Pamela J. | Derivatives Exercise | 3,300 | 2025-02-19 | ||
| Shulman Joseph | Sale | -1,228 | $57.22 | $70,266 | 2025-02-19 |
| Shulman Joseph | Derivatives Exercise | 4,125 | 2025-02-19 | ||
| Smith Hunter C | Sale | -2,215 | $57.22 | $126,742 | 2025-02-19 |
| Smith Hunter C | Derivatives Exercise | 6,600 | 2025-02-19 | ||
| Meeker David P | Sale | -9,896 | $57.22 | $566,249 | 2025-02-19 |
| Meeker David P | Derivatives Exercise | 21,250 | 2025-02-19 | ||
| Mazabraud Yann | Derivatives Exercise | 5,500 | 2025-02-19 | ||
| Smith Hunter C | Sale | -751 | $56.39 | $42,349 | 2025-02-14 |
| Shulman Joseph | Sale | -469 | $56.39 | $26,447 | 2025-02-14 |
| Lee Jennifer Kayden | Sale | -3,020 | $56.39 | $170,298 | 2025-02-14 |
| Smith Hunter C | Sale | -1,296 | $57.51 | $74,533 | 2025-02-11 |
| Smith Hunter C | Derivatives Exercise | 6,405 | 2025-02-11 | ||
| Shulman Joseph | Sale | -794 | $57.51 | $45,663 | 2025-02-11 |
| Shulman Joseph | Derivatives Exercise | 4,218 | 2025-02-11 | ||
| Lee Jennifer Kayden | Sale | -5,216 | $58.39 | $304,577 | 2025-02-11 |
| Lee Jennifer Kayden | Derivatives Exercise | 9,657 | 2025-02-11 | ||
| Cramer Pamela J. | Sale | -701 | $57.51 | $40,315 | 2025-02-11 |
| Cramer Pamela J. | Derivatives Exercise | 2,344 | 2025-02-11 | ||
| Lee Jennifer Kayden | Sale | -3,066 | $60.08 | $184,209 | 2025-02-07 |
| Cramer Pamela J. | Sale | -902 | $59.43 | $53,606 | 2025-02-04 |
| Cramer Pamela J. | Derivatives Exercise | 2,650 | 2025-02-04 | ||
| Lee Jennifer Kayden | Sale | -1,447 | $59.43 | $85,995 | 2025-02-04 |
| Lee Jennifer Kayden | Derivatives Exercise | 4,513 | 2025-02-04 | ||
| Meeker David P | Sale | -4,278 | $59.43 | $254,242 | 2025-02-04 |
| Meeker David P | Derivatives Exercise | 14,125 | 2025-02-04 | ||
| Smith Hunter C | Sale | -1,678 | $59.43 | $99,724 | 2025-02-04 |
| Smith Hunter C | Derivatives Exercise | 4,925 | 2025-02-04 | ||
| Shulman Joseph | Sale | -1,281 | $59.43 | $76,130 | 2025-02-04 |
| Shulman Joseph | Derivatives Exercise | 3,938 | 2025-02-04 | ||
| Shulman Joseph | Sale | -13,281 | $65.73 | $872,948 | 2024-11-13 |
| Shulman Joseph | Derivatives Exercise | 82,441 | 2024-11-13 | ||
| Lee Jennifer Kayden | Sale | -66,861 | $65.68 | $4,391,183 | 2024-11-13 |
| Lee Jennifer Kayden | Derivatives Exercise | 60,981 | 2024-11-13 | ||
| Cramer Pamela J. | Sale | -9,375 | $60 | $562,500 | 2024-11-08 |
| Cramer Pamela J. | Derivatives Exercise | 9,375 | 2024-11-08 | ||
| GOOD JENNIFER L | Sale | -31,751 | $52.4 | $1,663,803 | 2024-09-19 |
| GOOD JENNIFER L | Derivatives Exercise | 31,751 | 2024-09-19 | ||
| Cramer Pamela J. | Sale | -4,099 | $50.03 | $205,062 | 2024-09-11 |
| Cramer Pamela J. | Derivatives Exercise | 4,099 | 2024-09-11 | ||
| GOOD JENNIFER L | Sale | -37,241 | $50.45 | $1,878,700 | 2024-09-11 |
| GOOD JENNIFER L | Derivatives Exercise | 37,241 | 2024-09-11 | ||
| TETRAULT LYNN A. | Sale | -20,700 | $50.04 | $1,035,764 | 2024-09-11 |
| TETRAULT LYNN A. | Derivatives Exercise | 20,700 | 2024-09-11 | ||
| Cramer Pamela J. | Sale | -3,200 | $50.01 | $160,018 | 2024-08-28 |
| Cramer Pamela J. | Derivatives Exercise | 3,200 | 2024-08-28 | ||
| TETRAULT LYNN A. | Sale | -4,300 | $50.01 | $215,029 | 2024-08-28 |
| TETRAULT LYNN A. | Derivatives Exercise | 4,300 | 2024-08-28 | ||
| GOOD JENNIFER L | Sale | -14,508 | $50.01 | $725,526 | 2024-08-28 |
| GOOD JENNIFER L | Derivatives Exercise | 14,508 | 2024-08-28 | ||
| TETRAULT LYNN A. | Sale | -10,000 | $44.62 | $446,154 | 2024-08-14 |
| TETRAULT LYNN A. | Derivatives Exercise | 10,000 | 2024-08-14 | ||
| Cramer Pamela J. | Sale | -49,006 | $45.13 | $2,211,455 | 2024-08-13 |
| Cramer Pamela J. | Derivatives Exercise | 30,771 | 2024-08-13 | ||
| Cramer Pamela J. | Sale | -1,395 | $49.06 | $68,439 | 2024-07-30 |
| Cramer Pamela J. | Derivatives Exercise | 3,125 | 2024-07-30 | ||
| Shulman Joseph | Sale | -10,468 | $53 | $554,817 | 2024-07-18 |
| Shulman Joseph | Derivatives Exercise | 10,468 | 2024-07-18 | ||
| Shulman Joseph | Sale | -5,313 | $50.01 | $265,725 | 2024-07-16 |
| Shulman Joseph | Derivatives Exercise | 5,313 | 2024-07-16 | ||
| GOOD JENNIFER L | Derivatives Exercise | 3,000 | 2024-06-25 | ||
| Bedrosian Camille L | Derivatives Exercise | 3,000 | 2024-06-25 | ||
| JEAN CHRISTOPHE | Derivatives Exercise | 3,000 | 2024-06-25 | ||
| TETRAULT LYNN A. | Derivatives Exercise | 3,000 | 2024-06-25 | ||
| Arbuckle Stuart A | Derivatives Exercise | 3,000 | 2024-06-25 | ||
| MCGIRR DAVID W J | Derivatives Exercise | 3,000 | 2024-06-25 | ||
| Mathers Edward T | Derivatives Exercise | 3,000 | 2024-06-25 | ||
| Shulman Joseph | Sale | -3,984 | $38.38 | $152,896 | 2024-05-13 |
| Shulman Joseph | Derivatives Exercise | 3,984 | 2024-05-13 | ||
| Mazabraud Yann | Derivatives Exercise | -10,375 | 2024-04-16 | ||
| German Christopher Paul | Sale | -368 | $41.76 | $15,368 | 2024-04-03 |
| German Christopher Paul | Derivatives Exercise | 1,163 | 2024-04-03 | ||
| Lee Jennifer Kayden | Sale | -18,235 | $38.22 | $696,942 | 2024-03-22 |
| Shulman Joseph | Sale | -18,235 | $40.34 | $735,600 | 2024-03-22 |
| Shulman Joseph | Sale | -15,515 | $39.22 | $608,498 | 2024-03-19 |
| Lee Jennifer Kayden | Sale | -15,515 | $39.22 | $608,498 | 2024-03-19 |
| Cramer Pamela J. | Sale | -15,515 | $39.22 | $608,498 | 2024-03-19 |
| Meeker David P | Sale | -45,494 | $39.22 | $1,784,275 | 2024-03-19 |
| Mazabraud Yann | Sale | -16,000 | $39.22 | $627,520 | 2024-03-19 |
| Smith Hunter C | Sale | -15,515 | $39.22 | $608,498 | 2024-03-19 |
The information provided in this report about RYTM stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Rhythm Pharmaceuticals, Inc(NASDAQ:RYTM)Â 
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of ...
Website: http://www.rhythmtx.com
Founded: 2008
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology